Finance

Pharmaceutical company reports net loss in second quarter

Published in Cancer Weekly, February 24th, 2004

Pharmacyclics, Inc., (PCYC) reported financial results for its second fiscal quarter ended December 31, 2003, with a net loss for the period of $7.4 million, or $0.46 per share, compared to a net loss of $6.8 million, or $0.42 per share, in the comparable period of fiscal 2003.

Research and development expenses for the three months ended December 31, 2003, were $6.2 million, compared to $5.8 million during the same period of the prior fiscal year.

While total research and development expenses increased $0.4 million, total personnel costs declined approximately $0.4 million, primarily due to reduced headcount.

These savings were...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-02-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry